Literature DB >> 3677844

In vitro comparison of DeVilbiss jet and ultrasonic nebulizers.

S P Newman1, P G Pellow, S W Clarke.   

Abstract

Output, droplet size (by laser instrument), and nebulization time have been compared in vitro for eight individual ultrasonic nebulizers (DeVilbiss Pulmosonic) and eight individual jet nebulizers (DeVilbiss 646), the latter operated by compressed air at flows of 6 and 12 L/min. A solution of hypertonic (7 percent) saline was nebulized. The ultrasonic nebulizer retained a higher "dead" volume of solution on completion of nebulization (p less than 0.05), but the increase in saline concentration was less marked than for the jet (p less than 0.01). The mass of NaCl released as aerosol was similar for the ultrasonic and for the jet at 6 L/min but was increased for the jet at 12 L/min (p less than 0.05). There was a fivefold interindividual variation in output for the ultrasonic. Droplet mass median diameters for the ultrasonic (mean 5.4 micron) were slightly lower than those for the jet at 6 L/min (mean 6.0 micron, p less than 0.05) but were higher than those for the jet at 12 L/min (mean 3.7 micron, p less than 0.01). The ultrasonic emitted virtually no droplets less than 2 micron diameter and may be unsuitable for applications requiring high yields of fine particles for delivery to the peripheral lung regions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677844     DOI: 10.1378/chest.92.6.991

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Delivery of therapeutic aerosols to intubated babies.

Authors:  J Grigg; S Arnon; T Jones; A Clarke; M Silverman
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.

Authors:  J H Dennis; S C Stenton; J R Beach; A J Avery; E H Walters; D J Hendrick
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

Review 3.  Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia.

Authors:  J P Monk; P Benfield
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

4.  Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.

Authors:  O N McCallion; K M Taylor; M Thomas; A J Taylor
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

Review 5.  Aerosol antibiotic treatment in cystic fibrosis.

Authors:  J M Littlewood; S W Smye; H Cunliffe
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.